MA
Mastercard · Sep 17, 2026
$567.93
Shares
Hold
Fair value $586; the price is close to it, 3% under (range $419–$655, 4 of 4 models).
How we value it ›Prices as of 2:51 PM ET, Sep 17. Check the live quote before you send an order.
The put
Skip
Skip the put. The money looks good, but MA swings more than it pays. Want MA? Buy shares.
If it goes against you: you buy 100 shares at $560, which after the $920 you keep works out to $550.80 a share. Below $550.80 you are down on the trade. From that day the shares take above is the one that applies.
The order, if you sell it anyway
You get$920 (limit about $9.20)
If it fallsBuy 100 shares at $560
Cash to hold$56,000
Close earlyBuy back at about $4.60 ($460)
Chance you buy the sharesabout 38 in 100
ContractMA Oct 16 $560 put
ActionSell to open
In your broker app: open the stock → Trade → Options → Sell to open → pick the contract shown here.
Why skip
The put: Oct 16, $560 strike, 29 days out. Pays $920. Roughly a 38-in-100 chance you end up buying the shares.
On paper: 21% a year. That number assumes MA keeps moving like it did the past two years. Take that away and it is -3% a year. That is why we say skip.
Next earnings Oct 29, after this put ends. We never sell a put across a report.
If you already own 100 shares
Income call
For income on MA you already hold: sell the Oct 16 $605 call and take $238 now. If MA climbs to $605 by Oct 16, your 100 shares are sold at $605, so only do it if you're happy selling there.
If it climbs past $605 your 100 shares are sold at $605 and you keep the $238. That is the trade working, not a loss.
The call order
ActionSell to open
ContractMA Oct 16 $605 call
You get$238 (limit about $2.38)
If it climbsYour 100 shares sell at $605
Chance your shares are soldabout 15 in 100
After removing the trend-5% a year
First take on MA. Result Oct 16. See the record
Everyone sees the same card. It is not advice for you personally. You can lose more than you collect.
PrivacyTermsHow to read thisHow we value itThe recordPerformance简体中文繁體中文한국어日本語DipBell by cleo research